s6y

Lexaria Bioscience Corp.

Ticker
LEXX
CIK
1348362
Industry
Pharmaceutical Preparations
Formerly
Lexaria Corp., LEXARIA CORP.

Financials 83

  1. 10-Q Quarterly Report for period ending May 31, 2026
  2. 10-Q Quarterly Report for period ending Feb 28, 2026
  3. 10-Q Quarterly Report for period ending Nov 30, 2025
  4. 10-K Annual Report for period ending Aug 31, 2025
  5. 10-Q Quarterly Report for period ending May 31, 2025
  6. 10-Q Quarterly Report for period ending Feb 28, 2025
  7. 10-Q Quarterly Report for period ending Nov 30, 2024
  8. 10-K Annual Report for period ending Aug 31, 2024
  9. 10-Q Quarterly Report for period ending May 31, 2024
  10. 10-Q Quarterly Report for period ending Feb 29, 2024

All 83 financials filings

News 381

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 381 news filings

Ownership 441

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 441 ownership filings

Prospectus 61

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-3 Registration statement for specified transactions by certain issuers
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-3 Registration statement for specified transactions by certain issuers
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 61 prospectus filings

Proxies 26

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 26 proxies filings

Other 107

  1. SCHEDULE 13G
  2. EFFECT Notice of Effectiveness
  3. D Exempt (Private) Offering
  4. EFFECT Notice of Effectiveness
  5. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  6. D Exempt (Private) Offering
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 107 other filings